Deuterated ("heavy") water labeling in patients with chronic lymphocytic leukemia (CLL) demonstrates that IGHV unmutated and ZAP-70+ patients have higher blood and tissue CLL death rates on ibrutinib therapy, resulting in lower measurable residual disease levels with long-term ibrutinib treatment. This trial was registered at www.clinicaltrials.gov as #NCT01752426.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2024025683DOI Listing

Publication Analysis

Top Keywords

water labeling
8
deuterated water
4
labeling ibrutinib-treated
4
ibrutinib-treated patients
4
patients cll
4
cll leukemia
4
leukemia cell
4
cell kinetics
4
kinetics correlate
4
correlate ighv
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!